Clinical Trial: CD4 in Combination With CHOP in Treating Non-cutaneous Peripheral TCell Lymphoma
Study Status: Terminated
Recruit Status: Terminated
Study Type: Interventional
Official Title: A Multicentre Open-label Dose Escalation Tiral of Zanolimumab in Combination With CHOP Chemotherapy in Patients With CD4 Positive Non-cutaneous Peripheral T-cell Lymphoma
Brief Summary: Evaluation of CD4 in combination with CHO chemotherapy in subjects with nodal involvement of non cutaneous Tcell lymphoma.
Detailed Summary:
Sponsor: Emergent BioSolutions
Current Primary Outcome:
Original Primary Outcome:
Current Secondary Outcome:
Original Secondary Outcome:
Information By: Emergent BioSolutions
Dates:
Date Received: May 5, 2009
Date Started: May 2007
Date Completion:
Last Updated: February 25, 2013
Last Verified: February 2013